BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 117 filers reported holding BIOSCRIP INC in Q1 2015. The put-call ratio across all filers is 2.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $255,000 | -23.9% | 36,450 | -24.8% | 0.30% | -31.7% |
Q3 2014 | $335,000 | -25.2% | 48,500 | -9.8% | 0.43% | -33.2% |
Q2 2014 | $448,000 | +194.7% | 53,750 | +147.1% | 0.65% | +156.7% |
Q1 2014 | $152,000 | +2071.4% | 21,750 | +2075.0% | 0.25% | +2190.9% |
Q4 2013 | $7,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |